Author:
Kim Ja-Young,Park Yeon-Joon,Kim Sang-Il,Kang Moon Won,Lee Seung-Ok,Lee Kyo-Young
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference10 articles.
1. Luzzaro, F., Perilli, M., Amicosante, G. et al. (2001). Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of β-lactam/β-lactamase inhibitor combinations. International Journal of Antimicrobial Agents17, 131–5.
2. Naas, T., Benaoudia, F., Massuard, S. et al. (2000). Integron-located VEB-1 extended-spectrum β-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. Journal of Antimicrobial Chemotherapy46, 703–11.
3. Poirel, L., Naas, T., Guibert, M. et al. (1999). Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrobial Agents and Chemotherapy43, 573–81.
4. Girlich, D., Poirel, L., Leelaporn, A. et al. (2001). Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. Journal of Clinical Microbiology39, 175–82.
5. Naas, T., Poirel, L., Karim, A. et al. (1999). Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiology Letters176, 411–9.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献